Posted inComunicati
POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN’S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Repatha is the Only PCSK9 Inhibitor Proven to Significantly Reduce…
diretta News